Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 14;6(3):233-245.
doi: 10.31662/jmaj.2022-0184. Epub 2023 Jun 19.

Studies of Health Insurance Claims Data in Japan: A Scoping Review

Affiliations

Studies of Health Insurance Claims Data in Japan: A Scoping Review

Maiko Suto et al. JMA J. .

Abstract

Background: Health insurance claims data are used in various research fields; however, an overview on how they are used in healthcare research is scarce in Japan. Therefore, we conducted a scoping review to systematically map the relevant studies using Japanese claims data.

Methods: MEDLINE, EMBASE, and Ichushi-Web were searched up to April 2021 for studies using Japanese healthcare claims data. We abstracted the data on study characteristics and summarized target diseases and research themes by the types of claims database. Moreover, we described the results of studies that aimed to compare health insurance claims data with other data sources narratively.

Results: A total of 1,493 studies were included. Overall, the most common disease classifications were "Diseases of the circulatory system" (18.8%, n = 281), "Endocrine, nutritional, and metabolic diseases" (11.5%, n = 171; mostly diabetes), and "Neoplasms" (10.9%, n = 162), and the most common research themes were "medical treatment status" (30.0%, n = 448), "intervention effect" (29.9%, n = 447), and "clinical epidemiology, course of diseases" (27.9%, n = 417). Frequent diseases and themes varied by type of claims databases. A total of 19 studies aimed to assess the validity of the claims-based definition, and 21 aimed to compare the results of claims data with other data sources. Most studies that assessed the validity of claims data compared to medical records were hospital-based, with a small number of institutions.

Conclusions: Claims data are used in various research areas and will increasingly provide important evidence for healthcare policy in Japan. It is important to use previous claims database studies and share information on methodology among researchers, including validation studies, while informing policymakers about the applicability of claims data for healthcare planning and management.

Keywords: Japan; health insurance claims; healthcare policy; scoping review; validation studies.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1.
Figure 1.
Study selection flowchart.
Figure 2.
Figure 2.
Annual number of publications between 2010 and 2021 National Database of Health Insurance Claims (NDB); JMDC Claims Database (JMDC); Medical Data Vision EBM Provider (MDV); Diagnosis Procedure Combination Database (DPC); National Health Insurance (NHI), including Kokuho Database (KDB)/Latter-Stage Elderly Healthcare System (LSEHS); Japan Health Insurance Association (JHIA).

References

    1. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323-37. - PubMed
    1. Martin-Latry K, Bégaud B. Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf. 2010;19(3):256-65. - PubMed
    1. Tricco AC, Pham B, Rawson NS. Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions. J Clin Epidemiol. 2008;61(2):192-7. - PubMed
    1. Hoffmann F. Review on use of German health insurance medication claims data for epidemiological research. Pharmacoepidemiol Drug Saf. 2009;18(5):349-56. - PubMed
    1. Koram N, Delgado M, Stark JH, et al. Validation studies of claims data in the Asia-Pacific region: a comprehensive review. Pharmacoepidemiol Drug Saf. 2019;28(2):156-70. - PubMed

Publication types

LinkOut - more resources